AI Terminal
SEED INNOVATIONS LIMITED
AGM Information • Sep 7, 2022
7909_dva_2022-09-07_87389edb-c11a-4252-bab7-12c0d9061cba.html
AGM Information
Open in ViewerOpens in native device viewer
National Storage Mechanism | Additional information 
RNS Number : 6628Y
Seed Innovations Limited
07 September 2022
Seed Innovations Ltd / AIM: SEED / Sector: Closed End Investments
07 September 2022
SEED Innovations Limited ("SEED" or the "Company")
Result of AGM & Updated Investor Presentation
SEED Innovations Ltd, the AIM quoted company focusing on making investments in fast growing and industry leading businesses with a focus on the medical cannabis, health and wellness space, is pleased to announce that at the Annual General Meeting held earlier today, all resolutions which were proposed to shareholders were duly passed.
A copy of the Company's updated corporate presentation is now available on the website: www.seedinnovations.co
***ENDS***
For further information on the Company please visit www.seedinnovations.co or contact:
| Ed McDermott / Lance de Jersey |
SEED Innovations Ltd | Email: [email protected] |
| James Biddle / Roland Cornish |
Beaumont Cornish Limited, Nomad |
Tel: +44 (0) 207 628 3396 |
| Isabella Pierre / Damon Heath |
Shard Capital Partners LLP | T: +44 (0)20 7186 9927 |
| Catherine Leftley / Max Bennett / Isabelle Morris | St Brides Partners Ltd, Financial PR |
Email: [email protected] |
Notes
SEED Innovations is an AIM quoted investment company focused primarily on disruptive high growth life sciences and technology businesses particularly within the medical cannabis arena. The Company's strategy is to identify early-stage opportunities that have an upcoming investment catalyst and grow its portfolio in terms of value whilst limiting the number of investee companies to a level where relevant time can be devoted to each.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
RAGZDLFBLKLFBBE